drugset / Trial / NCT00029536

Summary

The purpose of this investigation was to determine if cyclic adjunctive progesterone supplement is superior to placebo in the treatment of intractable seizures in women with and without catamenial epilepsy.

Timeline

Start
2000-10
Primary completion
2010-06
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Progesterone Other / unclassified 200 mg

Indications